OCT for Neuro Ophthalmic Disorders
Speaker: Leonard Messner, O.D. Optical coherence tomography OCT has become a standard imaging study for patients with optic neuropathies and related afferent visual pathway disorders. This lecture provides a detailed overview of OCT findings in the setting of papilledema vs. pseudopapilledema. In addition, the utilization of OCT as a surrogate biomarker of neurologic disease is reviewed as related to multiple sclerosis, Alzheimers disease, Parkinsons disease and traumatic brain injury.
▶︎
OCT in Neuro ophthalmic Disorders
▶︎
Neuro-Op Near Misses
▶︎
Metabolic Drivers of Ocular Damage Insulin Resistance, GLP-1, Muscle Health, & Antioxidants
▶︎
Differentiating Papilledema from Pseudopapilledema with OCT | SPECTRALIS
▶︎
Meet the Researcher: Dr Claire Behan - Finding a way to predict seizures
▶︎
The Eyes as a Window to Systemic Disease
▶︎
What Symptom Does Each Multiple Sclerosis MRI Lesion Cause? Neurologist Explains
▶︎
OCT and Visual Field Pearls Through Glaucoma Case Discussion
▶︎
Optic Neuritis: It's not just multiple sclerosis anymore - John Chen, MD, PhD
▶︎
LRR Pediatrics for FMGE 2026 By Dr. Meenakshi Bothra
▶︎
Macular OCT Interpretation: A Practical Discussion with Dr. David E. Lederer
▶︎
New Horizons in Glaucoma Diagnostics
▶︎
Treatment Options for Essential Tremor & Parkinson's Disease - Webinar & Live Q&A with Drew Kern, MD
▶︎
Optimizing OCT for Optic Nerve Edema in Pediatric and Adult Patients
▶︎
The Practical Approach to the Glaucoma Suspect
▶︎
Visual Involvement in MS: Optic Neuritis and Optical Coherence Tomography
▶︎
Anterior Segment Challenges
▶︎
Toxic optic neuropathy
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎